{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:17:25Z","timestamp":1785323845694,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T00:00:00Z","timestamp":1244678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00011-009-0053-3","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T09:07:42Z","timestamp":1244624862000},"page":"819-827","source":"Crossref","is-referenced-by-count":61,"title":["Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice"],"prefix":"10.1007","volume":"58","author":[{"given":"John J.","family":"Byrnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Ellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Picarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,11]]},"reference":[{"key":"53_CR1","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus","year":"2004","unstructured":"Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterol. 2004;126:1504\u201317.","journal-title":"Gastroenterol"},{"key":"53_CR2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417\u201329.","journal-title":"N Engl J Med"},{"key":"53_CR3","first-page":"458","volume":"8","author":"JH Cho","year":"2008","unstructured":"Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev. 2008;8:458\u201366.","journal-title":"Nat Rev"},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1443-9573.2007.00287.x","volume":"8","author":"JA Katz","year":"2007","unstructured":"Katz JA. Management of inflammatory bowel disease in adults. J Dig Dis. 2007;8:65\u201371.","journal-title":"J Dig Dis"},{"key":"53_CR5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","volume":"24","author":"LJ Derijks","year":"2006","unstructured":"Derijks LJ, Gilissen LP, Hooymans PM, Hommes DW. Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24:715\u201329.","journal-title":"Aliment Pharmacol Ther"},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.gtc.2006.09.005","volume":"35","author":"PL Kozuch","year":"2006","unstructured":"Kozuch PL, Hanauer SB. General principles and pharmacology of biologics in inflammatory bowel disease. Gastroenterol Clin N Am. 2006;35:757\u201373.","journal-title":"Gastroenterol Clin N Am"},{"key":"53_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ Res. 2000;87:1\u20139.","journal-title":"Circ Res"},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275:33238\u201343.","journal-title":"J Biol Chem"},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bcp.2007.08.012","volume":"75","author":"DW Lambert","year":"2008","unstructured":"Lambert DW, Hooper NM, Turner AJ. Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem Pharmacol. 2008;75:781\u20136.","journal-title":"Biochem Pharmacol"},{"key":"53_CR10","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","volume":"277","author":"C Vickers","year":"2002","unstructured":"Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase (ACE2). J Biol Chem. 2002;277:14838\u201343.","journal-title":"J Biol Chem"},{"key":"53_CR11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1113\/expphysiol.2007.040014","volume":"93","author":"SB Gurley","year":"2008","unstructured":"Gurley SB, Coffman TM. Gene targeting studies of ACE2 in cardiovascular physiology: mixed messages. Exp Physiol. 2008;93:538\u201342.","journal-title":"Exp Physiol"},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","volume":"13","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Crackower MA, Backx PH, Penninger JM. The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med. 2003;13:93\u2013101.","journal-title":"Trends Cardiovasc Med"},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2162","volume":"212","author":"I Hamming","year":"2007","unstructured":"Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus ADME, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212:1\u201311.","journal-title":"J Pathol"},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol. 2004;203:631\u20137.","journal-title":"J Pathol"},{"key":"53_CR15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","volume":"532","author":"D Harmer","year":"2002","unstructured":"Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532:107\u201310.","journal-title":"FEBS Lett"},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.peptides.2005.01.009","volume":"26","author":"F Gembardt","year":"2005","unstructured":"Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP, et al. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides. 2005;26:1270\u20137.","journal-title":"Peptides"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/002215540205000215","volume":"50","author":"K Hirasawa","year":"2002","unstructured":"Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H. Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem. 2002;50:275\u201382.","journal-title":"J Histochem Cytochem"},{"key":"53_CR18","unstructured":"Malstrom S, Tyler S, Ellard C, Collins H, Coopersmith R, Barnes T, White D, Tartaglia L. Use of in vivo bio-photonic imaging to identify novel therapeutic utility for use of the ACE2 inhibitor GL1001 for treating inflammatory disorders of the gastrointestinal tract. Paper presented at IBC 13th annual world congress, drug discovery & development of innovative therapeutics 2008 Aug; Boston, MA."},{"key":"53_CR19","unstructured":"Malstrom S, Ellard C, Collins H, Coopersmith B, Barnes T, White D, Dimitrov L, Tartaglia L. Using in vivo biophotonic imaging in the repositioning of an ACE2 inhibitor. Paper presented at GTCbio conference, imaging in preclinical and clinical drug development 2007 Mar; Boston, MA."},{"key":"53_CR20","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1021\/ja0277226","volume":"124","author":"NA Dales","year":"2002","unstructured":"Dales NA, Gould AE, Brown JA, Calderwood EF, Guan B, Minor CA, et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J Am Chem Soc. 2002;124:11852\u20133.","journal-title":"J Am Chem Soc"},{"key":"53_CR21","first-page":"S14","volume":"S14","author":"LM Guzman","year":"2008","unstructured":"Guzman LM, Odate S, Boiselle CA, Gross SB, Wallace JL, Coopersmith R, et al. GL1001 inhibition of ACE2 is gastroprotective in rat models of gastritits. Inflamm Bowel Dis. 2008;S14:S14.","journal-title":"Inflamm Bowel Dis"},{"key":"53_CR22","doi-asserted-by":"crossref","unstructured":"Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694\u2013702.","DOI":"10.1016\/0016-5085(90)90290-H"},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0003-2697(90)90286-I","volume":"185","author":"K Somersalo","year":"1990","unstructured":"Somersalo K, Salo OP, Bjorksten F, Mustakalio KK. A simplified Boyden chamber assay for neutrophil chemotaxis based on quantitation of myeloperoxidase. Anal Biochem. 1990;185:238\u201342.","journal-title":"Anal Biochem"},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2036.1998.00357.x","volume":"12","author":"LG Axelsson","year":"1998","unstructured":"Axelsson LG, Landstrom E, Bylund-Fellenius AC. Experimental colitis induced by dextran sulfate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther. 1998;12:925\u201334.","journal-title":"Aliment Pharmacol Ther"},{"key":"53_CR25","unstructured":"Murthy S, Flanigan A. Animal models of inflammatory bowel disease. In: Morgan DW, Marshall LA, editors. In vivo models of inflammation. Basel: Birkhauser-Verlag, 1999. p. 205\u201329."},{"key":"53_CR26","first-page":"C101","volume":"36","author":"U Werner","year":"1992","unstructured":"Werner U, Szelenyi I. Measurement of MPO activity as model for detection of granulocyte infiltration into different tissues. Inflamm Res. 1992;36:C101\u20133.","journal-title":"Inflamm Res"},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"G504","DOI":"10.1152\/ajpgi.1989.257.4.G504","volume":"257","author":"KA Duggan","year":"1989","unstructured":"Duggan KA, Mendelsohn FAO, Levens NR. Angiotensin receptors and angiotensin I-converting enzyme in rat intestine. Am J Physiol Gastrointest Liver Physiol. 1989;257:G504\u201310.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"53_CR28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul M, Mehr AP, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747\u2013803.","journal-title":"Physiol Rev"},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0016-5085(90)91088-N","volume":"98","author":"R Jaszewski","year":"1990","unstructured":"Jaszewski R, Tolia V, Ehrinpreis MN, Bodzin JH, Peleman RR, Korlipara R, et al. Increased colonic mucosal angiotensin I and II concentrations in Crohn\u2019s colitis. Gastroenterol. 1990;98:1543\u20138.","journal-title":"Gastroenterol"},{"key":"53_CR30","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/j.1572-0241.2001.03945.x","volume":"96","author":"T Matsuda","year":"2001","unstructured":"Matsuda T, Suzuki J, Furuya K, Masutani M, Kawakami Y. Serum angiotensin I-converting enzyme is reduced in Crohn\u2019s disease and ulcerative colitis irrespective of genotype. Am J Gastroenterol. 2001;96:2705\u201310.","journal-title":"Am J Gastroenterol"},{"key":"53_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00011-007-7098-y","volume":"57","author":"K Katada","year":"2008","unstructured":"Katada K, Yoshida N, Suzuki T, Okuda T, Mizushima K, Takagi T, et al. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice. Inflamm Res. 2008;57:84\u201391.","journal-title":"Inflamm Res"},{"key":"53_CR32","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s10620-006-9124-2","volume":"52","author":"AU Spencer","year":"2007","unstructured":"Spencer AU, Yang H, Hazhija EQ, Wildhaber BE, Greenson JK, Teitelbaum DH. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci. 2007;52:1060\u201370.","journal-title":"Dig Dis Sci"},{"key":"53_CR33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.regpep.2007.10.004","volume":"146","author":"OI Santiago","year":"2008","unstructured":"Santiago OI, Rivera E, Ferder L, Appleyard CB. An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis. Regul Pept. 2008;146:250\u20139.","journal-title":"Regul Pept"},{"key":"53_CR34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","volume":"10","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens. 2001;10:321\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1592\/phco.2005.25.9.1213","volume":"25","author":"NJ Dagenais","year":"2005","unstructured":"Dagenais NJ, Jamali F. Protective effects of angiotensin II interruption: evidence for anti-inflammatory actions. Pharmacotherapy. 2005;25:1213\u201329.","journal-title":"Pharmacotherapy"},{"key":"53_CR36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardiores.2005.04.015","volume":"67","author":"S Guimaraes","year":"2005","unstructured":"Guimaraes S, Pinheiro H. Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally. Cardiovasc Res. 2005;67:208\u201315.","journal-title":"Cardiovasc Res"},{"key":"53_CR37","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1016\/j.bmc.2006.05.019","volume":"14","author":"J Georgsson","year":"2006","unstructured":"Georgsson J, Rosenstrom U, Wallinder C, Beaudry H, Plouffe B, Lindeberg G, et al. Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity. Bioorg Med Chem. 2006;14:5963\u201372.","journal-title":"Bioorg Med Chem"},{"key":"53_CR38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","volume":"264","author":"F Fyhrquist","year":"2008","unstructured":"Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264:224\u201336.","journal-title":"J Intern Med"},{"key":"53_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1399-3011.2004.00184.x","volume":"64","author":"U Rosenstrom","year":"2004","unstructured":"Rosenstrom U, Skold C, Lindeberg G, Botros M, Nyberg F, Hallberg A, et al. Synthesis and AT2 receptor-binding properties of angiotensin II analogues. J Pept Res. 2004;64:194\u2013201.","journal-title":"J Pept Res"},{"key":"53_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.regpep.2007.02.002","volume":"142","author":"S Han","year":"2007","unstructured":"Han S, Wang G, Qiu S, de la Motte C, Wang HQ, Gomez G, et al. Increased colonic apelin production in rodents with experimental colitis and in humans with IBD. Regul Pept. 2007;142:131\u20137.","journal-title":"Regul Pept"},{"key":"53_CR41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/gut.2005.079483","volume":"55","author":"M Peracchi","year":"2006","unstructured":"Peracchi M, Bardella MT, Caprioli F, Massironi S, Conte D, Valenti L, et al. Circulating ghrelin levels in patients with inflammatory bowel disease. Gut. 2006;55:432\u20133.","journal-title":"Gut"},{"key":"53_CR42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drudis.2007.10.024","volume":"13","author":"GJ Sanger","year":"2008","unstructured":"Sanger GJ. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov Today. 2008;13:234\u20139.","journal-title":"Drug Discov Today"},{"key":"53_CR43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1152\/ajpendo.00196.2004","volume":"288","author":"M Granado","year":"2005","unstructured":"Granado M, Priego T, Martin AI, Villan\u00faa MA, L\u00f3pez-Calder\u00f3n A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab. 2005;288:486\u201392.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"53_CR44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","volume":"143","author":"T Waseem","year":"2008","unstructured":"Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery. 2008;143:334\u201342.","journal-title":"Surgery"},{"key":"53_CR45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.regpep.2004.02.010","volume":"120","author":"T Brzozowski","year":"2004","unstructured":"Brzozowski T, Konturek PC, Konturek SJ, Kwiecien S, Drozdowicz D, Bielanski W, et al. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept. 2004;120:39\u201351.","journal-title":"Regul Pept"},{"key":"53_CR46","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1053\/j.gastro.2006.01.041","volume":"130","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006;130:1707\u201320.","journal-title":"Gastroenterology"},{"key":"53_CR47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tips.2006.02.006","volume":"27","author":"DK Lee","year":"2006","unstructured":"Lee DK, George SR, O\u2019Dowd BF. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmocol Sci. 2006;27:190\u20134.","journal-title":"Trends Pharmocol Sci"},{"key":"53_CR48","first-page":"3343","volume":"118","author":"HJ Chun","year":"2008","unstructured":"Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest. 2008;118:3343\u201354.","journal-title":"J Clin Invest"},{"key":"53_CR49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pharmthera.2005.04.001","volume":"107","author":"MJ Kleinz","year":"2005","unstructured":"Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005;107:198\u2013211.","journal-title":"Pharmacol Ther"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-009-0053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-009-0053-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-009-0053-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T09:49:09Z","timestamp":1558518549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-009-0053-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s00011-009-0053-3","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,11]]}}}